ArticleOncogene2019

Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer.

Yingqiu Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.